3309.HK
Strong BuyUnloved QualityAI neutralC-MER Medical Holdings Limited · Healthcare · Hong Kong · $120M
HKD 0.775 -1.9% · close 8 Oct · scored 9 Oct
Unloved Quality: Strong and cheap; the market has not turned yet.
As of 9 Oct 2026, MoatMap's StockRank for C-MER Medical Holdings Limited (3309.HK) is 84/100: Quality 62, Value 91, Momentum 27, ranked against 24,000+ stocks in 35 markets.
Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
C-MER Medical runs eye-care and dental clinics in Hong Kong and mainland China and has been buying back shares steadily. The stock screens as very cheap, but the rating reflects weak mainland consumer spending on elective procedures and price competition. No evidence points to a turn in earnings.
ABOUT C-MER MEDICAL HOLDINGS LIMITED
Read
C-MER Medical Holdings Limited provides specialty ophthalmic services, dental, and other medical services across Hong Kong and the Greater Bay Area. The company leverages its strong brand equity and clinical expertise established by founder Dr. Dennis Lam to capture premium private healthcare demand. It operates as a leading private eye care service provider with a growing network of eye hospitals and clinics.
FINANCIAL SUMMARY (HKD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 1.7B | 1.9B | 1.9B | 1.9B | 4.0% | 2.0B |
| EPS (HKD) | -0.02 | 0.05 | -0.11 | 0.08 | 29.9% | 0.08 |
| Shares | 1.3B | 1.3B | 1.2B | 1.2B | -5.5% | 1.2B |
| Debt | 452.5M | 363.0M | 437.8M | 426.8M | -1.9% | 433.7M |
| Equity | 1.9B | 1.8B | 1.8B | 1.8B | -1.7% | — |
| Op CF | 164.9M | 361.2M | 283.1M | 283.3M | 19.8% | 393.8M |
| Inv CF | -195.7M | -245.4M | -174.7M | -142.6M | — | — |
| Fin CF | 293.7M | -242.9M | -194.9M | -221.3M | — | — |
Made a new 52-week low in the latest session, 62% below its 52-week high. The fall has not stopped yet.
Calmer than 67% of stocks we rank over the past year (33% a year).
How this is worked out
StockRank judges the business. The price check reads only the chart: it is the price side of the Momentum score, in words.
The rules: Still falling is a new 52-week low in the last two weeks, at least 25% below the high. Finding a floor is no new low since. Turning up is 20 or more trading days without a new low, at least 10% off it, and back above a rising 50-day average. In an uptrend is above the 200-day average and within 15% of the high.
In 2,112 US drawdowns since 2001, buying while the price was still falling was followed by a further 20% drop 42% of the time. Waiting for a turn like this one cut that to 33%, at about 7% higher prices and with no better returns. Part of that cut is simply not buying: 13% of falls never turned, and waiting kept those out. Among turns that were bought, 38% still fell another 20%, and 33% of turns were followed by a new low within six months. The benefit was largest in crashes such as 2008 and 2020.
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 3309.HK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 3309.HK | C-MER Medical Holdings Limited(you) | $120M | 84 | Strong Buy |
| 2138.HK | EC Healthcare | $83M | 83 | Strong Buy |
| 1830.HK | Perfect Medical Health Management Limited | $201M | 100 | Strong Buy |
| 2189.HK | Kato (Hong Kong) Holdings Limited | $63M | 98 | Strong Buy |
| 0648.HK | SoftMedx Healthcare Limited | $83M | 65 | Hold |
| 3886.HK | Town Health International Medical Group Limited | $142M | 49 | Hold |
| 2161.HK | JBM (Healthcare) Limited | $172M | 90 | Strong Buy |
| 0950.HK | Lee's Pharmaceutical Holdings Limited | $91M | 92 | Strong Buy |
| 0239.HK | Pak Fah Yeow International Limited | $98M | 100 | Strong Buy |
| 0690.HK | Uni-Bio Science Group Limited | $53M | 88 | Strong Buy |
Peer medians: ROE 6.4% · P/E 10.5x · Gross margin 43.2%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.